Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel

Sivan Gazit; Yaki Saciuk; Galit Perez; Asaf Peretz; Virginia E. Pitzer; Tal Patalon

doi:10.1101/2022.03.24.22272835

Data Availability

According to the Israel Ministry of Health regulations, individual-level data cannot be shared openly. Specific requests for remote access to de-identified community-level data should be referred to KSM, Maccabi Healthcare Services Research and Innovation Center.

Comments

medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions and read our Comment Policy before commenting. The content of a comment is not endorsed by medRxiv.

Community Reviews

medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors.

Community reviews for this article:

There are no community reviews for this paper.

Automated Evaluations

Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv.

Automated Evaluations:

There are no automated evaluations for this paper.

Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel

Data Availability

Subject Area

Citation Manager Formats

Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel

Data Availability

Subject Area

Follow this preprint